Evidence map›Paper›PMID 28413916›Full record

ArticleInhalation toxicology2017

Extent of allergic inflammation depends on intermittent versus continuous sensitization to house dust mite.

Jane Tully Jones, Dereje D Tassew, Lois K Herrera, Stephanie R Walton-Filipczak, Marena A Montera, Hitendra S Chand, Monica Delgado, Yohannes A Mebratu, Yohannes Tesfaigzi

Abstract read
In one paragraph

Article in Inhalation toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jane Tully Jonesa COPD Program, Lovelace Respiratory Research Institute , Albuquerque , NM , USA.
Dereje D Tassewa COPD Program, Lovelace Respiratory Research Institute , Albuquerque , NM , USA.
Lois K Herreraa COPD Program, Lovelace Respiratory Research Institute , Albuquerque , NM , USA.
Stephanie R Walton-Filipczaka COPD Program, Lovelace Respiratory Research Institute , Albuquerque , NM , USA.
Marena A Monteraa COPD Program, Lovelace Respiratory Research Institute , Albuquerque , NM , USA.
Hitendra S Chanda COPD Program, Lovelace Respiratory Research Institute , Albuquerque , NM , USA.
Monica Delgadoa COPD Program, Lovelace Respiratory Research Institute , Albuquerque , NM , USA.
Yohannes A Mebratua COPD Program, Lovelace Respiratory Research Institute , Albuquerque , NM , USA.
Yohannes Tesfaigzia COPD Program, Lovelace Respiratory Research Institute , Albuquerque , NM , USA.
Lovelace Respiratory Research Institute · US

Funding

RESPIRATORY RESEARCHT32HL007633 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI George R Washko · 1985 to 2026
$14.9M
Resolution of Epithelial Cell Hyperplasia in AsthmaR01HL068111 · NHLBI · LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE · PI TESFAIGZI, YOHANNES · 2003 to 2021
$10.9M
Resolution of Epithelial Cell HyperplasiaR01ES015482 · NIEHS · LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE · PI TESFAIGZI, YOHANNES · 2009 to 2013
$2.6M
Targeting Hyperplastic Airway Cells Using a Small Molecule InhibitorR21AI117560 · NIAID · LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE · PI CHAND, HITENDRA SINGH · 2016 to 2017
$510k
Regulation of Mucous Cell Metaplasia in AsthmaR56HL068111 · NHLBI · LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE · PI TESFAIGZI, YOHANNES · 2007 to 2007
$500k
NHLBI NIH HHS R01 HL068111NHLBI NIH HHS R56 HL068111NHLBI NIH HHS T32 HL007633NIAID NIH HHS R21 AI117560NIEHS NIH HHS R01 ES015482
6 · The paper itself

Abstract

objectiveHouse dust mite (HDM) exposure is used to model experimental asthma in mice. However, a direct comparison of inflammatory responses following continuous versus intermittent HDM exposure has not been reported. Therefore, we investigated whether the HDM dose at sensitization or challenge affects extent of inflammation in mice that were either continuously or intermittently sensitized with HDM. MATERIALS AND

methodsC57BL/6 mice received either 10 continuous exposures with 10 μg HDM per exposure or two intermittent HDM exposures over a period of two weeks and were subsequently challenged by three instillations with HDM during the third week. For the intermittent model, mice were sensitized with 1 or 10 μg HDM and challenged on three consecutive days with 1 or 10 μg HDM. Inflammatory cells in the bronchoalveolar lavage fluid and epithelial cell hyperplasia and mucous cell metaplasia were quantified.

resultsSignificantly higher levels of inflammation and mucous cell metaplasia were observed when mice were sensitized intermittently compared with continuously. Intermittent sensitization and challenge with 10 μg HDM caused maximum inflammation, mucous cell metaplasia, and epithelial cell hyperplasia. However, sensitization with 1 μg HDM only also showed increased inflammation when challenged with 10 μg HDM. DISCUSSION: These findings suggest major differences in adaptive immunity, depending on the sensitization protocol.

conclusionsBecause of significant differences, the HDM sensitization protocol should be carefully considered when designing studies to investigate the underlying mechanisms of immunity in mouse models of asthma.

Indexed as

Adaptive ImmunityAllergensAnimalsBronchoalveolar Lavage FluidEpithelial CellsHyperplasiaHypersensitivityInflammationLungMaleMice, Inbred C57BLPyroglyphidaeAllergensallergic sensitizationasthmaHouse dust miteinflammationmucous cell metaplasia

Identifiers

PMID28413916
PMCPMC6121731
OpenAlexW2607125753

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.